Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Jun. 30, 2019
Current assets:    
Cash $ 10,040 $ 4,421
Accounts receivable - trade 75 97
Prepaid expenses and other current assets 189 290
Total Current Assets 10,304 4,808
Finance lease right-of-use assets, net of accumulated amortization 28,031 0
Fixed assets, net of accumulated depreciation 2,657 24,380
Intangible assets, net of accumulated amortization 1,204 1,374
Security deposits 24 24
Total Assets 42,220 30,586
Current liabilities:    
Accounts payable (related parties of $19 and $125 as of March 31, 2020 and June 30, 2019, respectively) 547 1,001
Accrued expenses (related party of $840 and $699 as of March 31, 2020 and June 30, 2019, respectively) 1,135 965
Notes payable - warrant exchange 1,196  
Finance lease obligation - current portion 295 0
Capital lease obligation - current portion   213
Contract liabilities 3,006 1,279
Total Current Liabilities 6,179 3,458
Finance lease obligation - net of current portion 32,084 0
Capital lease obligation - net of current portion 0 24,671
Total Liabilities 38,263 28,129
Commitments and Contingencies
iBio, Inc. Stockholders' Equity:    
Common stock - $0.001 par value; 275,000,000 shares authorized; 107,360,032 and 20,152,458 shares issued and outstanding as of March 31, 2020 and June 30, 2019, respectively 107 20
Additional paid-in capital 150,774 108,295
Accumulated other comprehensive loss (33) (31)
Accumulated deficit (146,882) (105,821)
Total iBio, Inc. Stockholders' Equity 3,966 2,463
Noncontrolling interest (9) (6)
Total Equity 3,957 2,457
Total Liabilities and Equity 42,220 30,586
iBio CMO [Member]    
iBio, Inc. Stockholders' Equity:    
Preferred Stock, Value, Issued 0 0
Series A Preferred Stock [Member]    
iBio, Inc. Stockholders' Equity:    
Preferred Stock, Value, Issued 0 0
Series B Preferred Stock [Member]    
iBio, Inc. Stockholders' Equity:    
Preferred Stock, Value, Issued 0 0
Series C Preferred Stock [Member]    
iBio, Inc. Stockholders' Equity:    
Preferred Stock, Value, Issued $ 0 $ 0